Dewald G - Search Results

1

BCR/ABL-negative primitive progenitors suitable for transplantation can be selected from the marrow of most early-chronic phase but not accelerated-phase chronic myelogenous leukemia patients.

Verfaillie CM, Bhatia R, Miller W, Mortari F, Roy V, Burger S, McCullough J, Stieglbauer K, Dewald G, Heimfeld S, Miller JS, McGlave PB. Verfaillie CM, et al. Among authors: dewald g. Blood. 1996 Jun 1;87(11):4770-9. Blood. 1996. PMID: 8639848 Free article.

2

Abnormal function of the bone marrow microenvironment in chronic myelogenous leukemia: role of malignant stromal macrophages.

Bhatia R, McGlave PB, Dewald GW, Blazar BR, Verfaillie CM. Bhatia R, et al. Among authors: dewald gw. Blood. 1995 Jun 15;85(12):3636-45. Blood. 1995. PMID: 7780147 Free article.

3

Effect of recombinant gamma interferon on chronic myelogenous leukemia bone marrow progenitors.

McGlave P, Mamus S, Vilen B, Dewald G. McGlave P, et al. Among authors: dewald g. Exp Hematol. 1987 May;15(4):331-5. Exp Hematol. 1987. PMID: 3106077

4

Highly sensitive fluorescence in situ hybridization method to detect double BCR/ABL fusion and monitor response to therapy in chronic myeloid leukemia.

Dewald GW, Wyatt WA, Juneau AL, Carlson RO, Zinsmeister AR, Jalal SM, Spurbeck JL, Silver RT. Dewald GW, et al. Blood. 1998 May 1;91(9):3357-65. Blood. 1998. PMID: 9558393 Free article.

5

Karyotypic analysis in primary myelodysplastic syndromes.

Noël P, Tefferi A, Pierre RV, Jenkins RB, Dewald GW. Noël P, et al. Among authors: dewald gw. Blood Rev. 1993 Mar;7(1):10-8. doi: 10.1016/0268-960x(93)90019-z. Blood Rev. 1993. PMID: 8467227 Review.

6

CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy.

Pardanani A, Ketterling RP, Brockman SR, Flynn HC, Paternoster SF, Shearer BM, Reeder TL, Li CY, Cross NC, Cools J, Gilliland DG, Dewald GW, Tefferi A. Pardanani A, et al. Blood. 2003 Nov 1;102(9):3093-6. doi: 10.1182/blood-2003-05-1627. Epub 2003 Jul 3. Blood. 2003. PMID: 12842979 Free article.

7

The 5q- syndrome: a single-institution study of 43 consecutive patients.

Mathew P, Tefferi A, Dewald GW, Goldberg SL, Su J, Hoagland HC, Noel P. Mathew P, et al. Among authors: dewald gw. Blood. 1993 Feb 15;81(4):1040-5. Blood. 1993. PMID: 8427985 Free article.

8

A special fluorescent in situ hybridization technique to study peripheral blood and assess the effectiveness of interferon therapy in chronic myeloid leukemia.

Buño I, Wyatt WA, Zinsmeister AR, Dietz-Band J, Silver RT, Dewald GW. Buño I, et al. Among authors: dewald gw. Blood. 1998 Oct 1;92(7):2315-21. Blood. 1998. PMID: 9746769 Free article. Clinical Trial.

9

Atypical BCR and ABL D-FISH patterns in chronic myeloid leukemia and their possible role in therapy.

Dewald GW, Wyatt WA, Silver RT. Dewald GW, et al. Leuk Lymphoma. 1999 Aug;34(5-6):481-91. doi: 10.3109/10428199909058475. Leuk Lymphoma. 1999. PMID: 10492071

10

Myeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patients.

Fonseca R, Blood EA, Oken MM, Kyle RA, Dewald GW, Bailey RJ, Van Wier SA, Henderson KJ, Hoyer JD, Harrington D, Kay NE, Van Ness B, Greipp PR. Fonseca R, et al. Blood. 2002 May 15;99(10):3735-41. doi: 10.1182/blood.v99.10.3735. Blood. 2002. PMID: 11986230 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

297 results

Search Page